MERKEL CELL CARCINOMA, STAGE II

Clinical trials for MERKEL CELL CARCINOMA, STAGE II explained in plain language.

Never miss a new study

Get alerted when new MERKEL CELL CARCINOMA, STAGE II trials appear

Sign up with your email to follow new studies for MERKEL CELL CARCINOMA, STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug tested to stop rare skin cancer from spreading

Disease control Not yet recruiting

This study is testing whether a drug called cemiplimab, given before surgery, can help control early-stage Merkel cell carcinoma, a rare and aggressive skin cancer. It will involve about 135 adults whose main tumor has been removed but who are still waiting for a lymph node biops…

Matched conditions: MERKEL CELL CARCINOMA, STAGE II

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

MERKEL CELL CARCINOMA, STAGE II

Get alerted when new MERKEL CELL CARCINOMA, STAGE II trials appear

New drug tested to stop rare skin cancer from spreading